With notable strength in IP, clients frequently turn to Kirkland & Ellis International LLP for high-profile, multijurisdictional patent litigation involving small molecules, complex biologic products, medical devices, and diagnostics. The firm also advises investors and life sciences companies in technology and IP transactions, such as licensing and commercialisation agreements. The ‘exceptionally knowledgeable’ team is jointly led by ’star litigator’ Nicola Dagg; Daniel Lim, who draws on his biochemistry background to advise on patent litigation and IP strategy; and Emma Flett, experienced in the full spectrum of IP-related work, particularly high-value M&A. Other key figures include litigator Jin Ooi, praised for ‘combin(ing) deep technical knowledge with strategic thinking’. Gabriella Bornstein is no longer at the firm.
L'éditorial du Legal 500
Distinctions
La satisfaction du client: Qualité de l’avocat et de l’équipe
La satisfaction du client: Connaissance du secteur
Avocats
Leading partners
Avocats associés reconnus parmi les leaders du marché par leurs pairs et leurs clients, régulièrement présents dans les grands dossiers dans lesquels ils sont au premier plan.
Next Generation Partners
Jeunes associés disposant d'une reconnaissance montante sur le marché, jouant régulièrement un rôle clé dans des dossiers majeurs.
Responsable de la pratique
Daniel Lim; Nicola Dagg; Emma Flett
Autres avocats clés
Jin Ooi; Steven Baldwin; Alex Magnusdottir; Rory Clarke; Peter Pereira